ACTU vs ADBE · $49.0M cap vs P/E 11, rev $13.02B
Actuate Therapeutics, Inc. Common stock (ACTU) versus Adobe Systems Incorporated (ADBE) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
Adobe Systems Incorporated (ADBE) is a software - application company listed on NASDAQ. It is led by Shantanu Narayen.
ACTU does not have a complete income-statement cache yet.
Latest reported ADBE revenue for 2026-05-29 was $13.02B. Net income was $3.60B. ADBE currently screens at market cap $78.02B and trailing P/E 11.2.
ACTU currently screens at market cap $49.0M. ADBE currently screens at market cap $78.02B and trailing P/E 11.2.
Not investment advice. Open the ACTU and ADBE stock pages for the full models.
Not investment advice.